New drug approval: Olaparib and niraparib - first line in ovarian cancer

xlomafota13 shared this article with you from Inoreader New drug approval: Olaparib and niraparib - first line in ovarian cancer Via Association française pour l'étude du cancer Bull Cancer. 2021 Feb 25:S0007-4551(21)00038-2. doi: 10.1016/j.bulcan.2021.01.003. Online ahead of print. NO ABSTRACT PMID:33641880 | DOI:10.1016/j.bulcan.2021.01.003 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.